Legend Biotech (LEGN) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts LEGN Hot Sheet
Join SI Premium – FREE
Legend Biotech (NASDAQ: LEGN) reported Q4 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $306.3 million versus the consensus estimate of $310.71 million.
For earnings history and earnings-related data on Legend Biotech (LEGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet Sees FY26 Capex $195B To $205B, Saw $180B To $190B
- Wyndham Hotels & Resorts, Inc. (WH) Tops Q2 EPS by 8c ; Offers Guidance
- Chemung Financial (CHMG) Tops Q2 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
